The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control

Diabetes Technology and Therapeutics

Volumn 12, Issue 7, 2010, Pages 567-573

  Pinhas Hamiel, Orit ^a,b   Tzadok, Michal ^a,c   Hirsh, Galit ^c   Boyko, Valentina ^c   Graph Barel, Chana ^a   Lerner Geva, Liat ^b,c   Reichman, Brian ^b,c  

^a Maccabi Juvenile Diabetes Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC REGULATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT DURATION; DIABETES MELLITUS, TYPE 1; INSULIN INFUSION; METABOLISM; STATISTICAL MODEL;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS; LOGISTIC MODELS; MALE; RETROSPECTIVE STUDIES;

EID: 77954455219     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2010.0006     Document Type: Article

References (18)

1. Bode BW, Tamborlane WV, Davidson PC: Insulin pump therapy in the 21st century. Strategies for successful use in adults, adolescents, and children with diabetes. Postgrad Med 2002;111:69-77.
2. Bode BW, Sabbah HT, Gross TM, Fredrickson LP, Davidson PC: Diabetes management in the new millennium using insulin pump therapy.DiabetesMetab Res Rev 2002;18(Suppl 1): S14-S20.
3. Skogsberg L, Fors H, Hanas R, Chaplin JE, Lindman E, Skogsberg J: Improved treatment satisfaction but no difference in metabolic control when using continuous subcutaneous insulin infusion vs. multiple daily injections in children at onset of type 1 diabetes mellitus. Pediatr Diabetes 2008;9:472-479.
4. Tamborlane WV, Fredrickson LP, Ahern JH: Insulin pump therapy in childhood diabetes mellitus: guidelines for use. Treat Endocrinol 2003;2:11-21.
5. Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A: Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 2008;51:941-951.
6. Pańkowska E, B?azik M, Dziechciarz P, Szypowska A, Szajewska H: Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabetes 2009;10:52-58.
7. Scrimgeour L, Cobry E, McFann K, Burdick P, Weimer C, Slover R, Chase HP: Improved glycemic control after longterm insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 2007;9:421-428.
8. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605.
9. Plotnick LP, Clark LM, Brancati FL, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;26:1142-1146.
10. Hanas R, Adolfsson P: Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006;7:25-31.
11. Sulli N, Shashaj B: Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Diabet Med 2006;23:900-906.
12. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E; Diabetes Research in Children Network (Direc-Net) Study Group: Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005; 6:13-16.
13. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167.
14. Lombardo F, Iafusco D, Salzano G, Piscopo A, Saitta G, Pisani F, De Luca F, Prisco F: The egg or the chicken? Further data on whether good compliance to multi-injection insulin therapy should be a criterion for insulin pump therapy, or does insulin pump therapy improve compliance? J Pediatr 2007;151:e23-e24.
15. Iafusco D, Confetto S, Prisco F, Lombardo F, Salzano G, De Luca F: The egg or the chicken? Should good compliance to multi-injection insulin therapy be a criterion for insulin pump therapy, or does insulin pump therapy improve compliance? J Pediatr 2006;148:421-422.
16. Ramchandani N, Ten S, Anhalt H, Sinha S, Ching J, Finkelstein A, Maclaren NK: Insulin pump therapy from the time of diagnosis of type 1 diabetes. Diabetes Technol Ther 2006;8:663-670.
17. McVean JJ, Eickhoff JC, MacDonald MJ: Factors correlating with improved A1C in children using continuous subcutaneous insulin infusion. Diabetes Care 2007;30:2499-2500.
18. Willi SM, Planton J, Egede L, Schwarz S: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003;143:796-801.